Clinical Trials · NCT04524026

RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Nicholas Macklon
Enrollment
25
Start date
Sep 2018
Locations
2 sites, Denmark
Primary endpoint
Length of luteal phase (days from aspiration untill bleeding)
View Gonadorelin compound reference